Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 26, 2026

Measuring Changes in Tactile Sensitivity in the Hind Paw of Mice Using an Electronic von Frey Apparatus
07:49

Measuring Changes in Tactile Sensitivity in the Hind Paw of Mice Using an Electronic von Frey Apparatus

Published on: December 19, 2013

Improving synaptic function in a mouse model of AD.

Peter T Lansbury1

  • 1Department of Neurology, Harvard Medical School, 65 Landsdowne Street, Cambridge, MA 02139, USA.

Cell
|August 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice.

Molecular neurodegeneration·2022
Same author

Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein.

Neuron·2019
Same author

N-terminal deletion does not affect α-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast.

Journal of neurochemistry·2011
Same author

Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods.

Journal of medicinal chemistry·2010
Same author

The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast.

Journal of molecular biology·2009
Same author

Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Proceedings of the National Academy of Sciences of the United States of America·2009
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
See all related articles

Enhancing ubiquitin hydrolase UCH-L1 activity improved synaptic function and memory in a mouse model of Alzheimer's Disease (AD). This suggests UCH-L1 may be a therapeutic target for AD and potentially other protein aggregation diseases.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Memory loss is a primary symptom of Alzheimer's Disease (AD).
  • Synaptic dysfunction contributes to cognitive decline in AD.
  • Protein aggregation is implicated in neurodegenerative diseases like AD and Parkinson's Disease (PD).

Purpose of the Study:

  • To investigate the role of ubiquitin hydrolase UCH-L1 in a mouse model of AD.
  • To determine if enhancing UCH-L1 activity can alleviate AD-related symptoms.
  • To explore the potential implications of UCH-L1 for other protein aggregation disorders.

Main Methods:

  • Utilized a mouse model genetically engineered to exhibit AD-like pathology.
  • Administered interventions to modulate the activity of UCH-L1.

More Related Videos

In Vivo Wireless Optogenetic Control of Skilled Motor Behavior
07:52

In Vivo Wireless Optogenetic Control of Skilled Motor Behavior

Published on: November 22, 2021

A Real-Time Interactive System for Studying Confrontational Pursuit Behavior in Rodents
06:25

A Real-Time Interactive System for Studying Confrontational Pursuit Behavior in Rodents

Published on: May 16, 2025

Related Experiment Videos

Last Updated: Jun 26, 2026

Measuring Changes in Tactile Sensitivity in the Hind Paw of Mice Using an Electronic von Frey Apparatus
07:49

Measuring Changes in Tactile Sensitivity in the Hind Paw of Mice Using an Electronic von Frey Apparatus

Published on: December 19, 2013

In Vivo Wireless Optogenetic Control of Skilled Motor Behavior
07:52

In Vivo Wireless Optogenetic Control of Skilled Motor Behavior

Published on: November 22, 2021

A Real-Time Interactive System for Studying Confrontational Pursuit Behavior in Rodents
06:25

A Real-Time Interactive System for Studying Confrontational Pursuit Behavior in Rodents

Published on: May 16, 2025

  • Assessed synaptic function and memory performance in the AD mouse model.

    • Main Results:

    • Enhanced UCH-L1 activity was found to alleviate synaptic dysfunction in the AD mouse model.
    • Improvements in memory loss were observed following UCH-L1 enhancement.
    • The study provides evidence for UCH-L1's protective role against AD pathology.

    Conclusions:

    • UCH-L1 is a potential therapeutic target for mitigating memory loss in Alzheimer's Disease.
    • Modulating UCH-L1 activity may offer a novel therapeutic strategy for AD.
    • Further research is warranted to explore UCH-L1's role in other neurodegenerative diseases involving protein aggregation, such as Parkinson's Disease.